VACCINE AND TREATMENT EVALUATION UNITS: PHASE II VACCINE TRIAL FOR INFLUENZA

NIH RePORTER · NIH · N01 · $5,000 · view on reporter.nih.gov ↗

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations.

Key facts

NIH application ID: 10710347
Project number: 272201300018I-P00004-27200019-1
Recipient: EMORY UNIVERSITY
Principal Investigator: NADINE ROUPHAEL
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $5,000
Award type: —
Project period: 2017-07-28 → 2024-03-31